The 1980s is an era defined by rapid cultural and technological transformation, and it left an undeniable mark on horology ...

- Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...

There is no evidence that less frequent financial reporting impairs company performance, market functioning, or the quality of investor information.

Everglades detention facility "Planned in secret, built in secret, and has been operated in secret." Now, a suit challenging ...

Global listed infrastructure reasserted its value as a distinct allocation in 2025, delivering double-digit returns YTD. Read ...

At the ANA Masters of Marketing Conference in Florida, PwC’s Samrat Sharma unveiled new research that could finally settle ...

Thank you, Haley, and good morning. Welcome to InterDigital's Third Quarter 2025 Earnings Conference Call. I am Raiford Garrabrant, Head of Investor Relations for InterDigital. With me on today's call ...

"We're getting to the November 21 date that they had been eyeing to fund the government through," said Loren Duggan.

Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic neuromuscular diseases; ...

Ozekibart meets its primary endpoint in chondrosarcoma, demonstrating a statistically significant and clinically meaningful improvement in median progression-free ...

Learn how to calculate the present value of various bond types using Excel, including zero-coupon, annuities, and continuous ...

Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® (pegcetacoplan) in the first two months since launch in ...